Significance expression and relationships with endothelin-1,matrix metalloproteinase-9 in the laryngeal Carcinoma
-
摘要: 目的:探讨内皮素-1(ET-1)和基质金属蛋白酶-9(MMP-9)在喉癌中的表达情况及其与临床病理特征之间的相互关系。方法:采用免疫组织化学SP法检测58例喉癌、28例声带息肉及19例喉部正常黏膜组织中ET-1、MMP-9的表达。结果:喉癌组织中ET-1的表达率为81.03%(47/58),与声带息肉(57.14%)和喉部正常黏膜组织(57.89%)对比,差异有统计学意义(P<0.05)。MMP-9在喉癌中的表达率为72.41%(42/58),与声带息肉(50.00%)和喉部正常黏膜组织(47.37%)对比,差异有统计学差异(P<0.05)。ET-1、MMP-9的表达与喉癌的临床分期、浸润深度及有无淋巴结转移均有一定关系。结论:ET-1与MMP-9的高表达可能与喉癌的发生、发展关系密切,可为喉癌的靶向及个性化治疗策略提供一定的理论依据。Abstract: Objective: To evaluate the expression of endothelin-1(ET-1) and matrix metalloproteinase-9(MMP-9) in laryngeal carcinoma and their correlations with clinical features.Method: The expression of ET-1 and MMP-9 was detected by immunohistochemical method in 58 specimens of laryngeal carcinoma, 28 specimens of polyps of vocal cord and 19 specimens of normal laryngeal tissues.Result: The expressions of ET-1, MMP-9 in laryngeal carcinoma were remarkably higher,compared to polyps of vocal cord and normal laryngeal tissues(P<0.05). The expression of ET-1, MMP-9 was associated with clinical stage, T stage and lymph node metastasis. Expression levels of ET-1and MMP-9 correlated significantly with each other(rs=0.693,P<0.05).Conclusion: The expression of ET-1 and MMP-9 may be the vital indexes in laryngeal carcinoma.
-
Key words:
- endothelin-1 /
- matrix metalloproteinase-9 /
- laryngeal neoplasms
-
-
[1] 林雁,张京晶,刘世喜,等.内皮素A受体拮抗剂在人喉癌种植瘤的实验研究[J].华西医学,2009,24(10):2674-2676.
[2] BHALLA A, HAQUE S, TAYLOR I,et al. Endothelin receptor antagonism and cancer[J].Eur J Clin Invest,2009,39:74-77.
[3] 陈志刚,王红静,周羽,等.内皮素-1及其受体在子宫内膜异位症中的表达及意义[J].四川大学学报(医学版),2009,40(3):422-425.
[4] HERRMANN E,BOGEMANN M,BIERER S,et al.The role of the endothelin axis and microvessel density in bladder cancer-correlation with tumor angiogenesis and clinical prognosis [J].Oncol Rep,2007,18: 133-138.
[5] DAS S,BANERJI A,FREI E,et al. Rapid expression and activation of MMP-2 and MMP-9 upon exposure of human breast cancer cells(MCF-7) to fibro- nectin in serum free medium[J].Life Sci,2008,82:467-476.
[6] BECKER D P,BARTA T E,BEDELL L J,et al. Orally active MMP-1 sparing alpha- tetrahydropyranyl and alpha-piperidinyl sulfone matrix metallo- proteinase (MMP) inhibitors with efficacy in cancer, arthritis, and cardiovascular disease[J].J Med Chem,2010,53:6653-6680.
[7] SILLANPAA S,NTTILA M,OUTILAINEN K, et al. Prognostic significance of matrix metalloproteinase-9(MMP-9)in epithelial ovarian cancer[J]. Gynecol oncol,2007,104:296-303.
[8] SYMOWICZ J,ADLEY B,GLEASON K,et al. Engagement of collagen binding integrins promotes matrix metalloproteinase-9-dependent E-cadherin ectodomain shedding in ovarian carcinoma cells[J].Cancer,2007,67: 2030-2039.
[9] CAI K,YANG W,CAPO-CHICHI C,et al.Prominent expression of metallo proteinases in early stages of ovarian tumorigenesis[J].Mol Carcinog,2007,46:130-143.
[10] TANGY,ZHU J,CHEN L,et al.Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer[J].Clin Cancer Res,2008,14:2870-2877.
[11] NAKAMURA T,KUWAI T,KIM J S,et al. Stromal metalloproteinase-9 is essential to angiogenesis and progressive growth of orthotopic human pancreatic cancer in parabiont nude mice[J].Neoplasia,2007,9: 979-986.
[12] MAI H Q, ZENG Z Y, FENG K T. Therapeutic targeting of the endothelin a receptor in human nasopharyngeal carcinoma[J].Cancer Sci,2006, 97:1388-1395.
[13] FISCHGRABE J,GOTTE M,SMOLLICH M,et al.Impact of VEGF on the expression of the endothelin axis in human breast cancer cell lines[J]. Onkolocie,2008,31:31-32.
[14] ZHOU W Q,YIN H L,ZHANG Z Y, et al. Expression of VEGF in prostate cancer and its correlation with ET-1[J]. Zhong Hua Nan Ke Xue,2008,14: 987-992.
-
计量
- 文章访问数: 90
- PDF下载数: 62
- 施引文献: 0